Given the rising interest in NLRP3 inhibitors and the need for effective gout therapies beyond urate-lowering agents, this study evaluates the synergistic potential of allopurinol and disulfiram in treating hyperuricemia and gouty arthritis. The gene discussed is NLRP3; the disease is hyperuricemia.